Jason Scott Slakter
Vorstandsvorsitzender bei Jason S. Slakter MD PC
Aktive Positionen von Jason Scott Slakter
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
Macula Society | Corporate Officer/Principal | - | - |
The Retina Society | Corporate Officer/Principal | - | - |
American Society of Retinal Specialists | Corporate Officer/Principal | - | - |
Jason S. Slakter MD PC
Jason S. Slakter MD PC Medical/Nursing ServicesHealth Services Part of ProScan Imaging LLC, Jason S. Slakter MD PC is an ophthalmology imaging core lab. The company is based in Great Neck, NY. The company was founded in 1998 by Jason Scott Slakter and Jeffrey Schneebaum. Jason Scott Slakter has been the CEO since 1998. Jason S. Slakter MD was acquired by WorldCare Clinical LLC on September 03, 2021. | Vorstandsvorsitzender | 01.01.1998 | - |
Technik-/Wissenschafts-/F&E-Leiter | 01.01.1998 | - | |
Gründer | 01.01.1998 | - | |
New York University School of Medicine | Corporate Officer/Principal | - | - |
Vitreous Retina Macula Consultants of New York | Corporate Officer/Principal | - | - |
American Ophthalmological Society
American Ophthalmological Society Miscellaneous Commercial ServicesCommercial Services The American Ophthalmological Society is an organization that aims to promote excellence in patient care, education, and research in the field of ophthalmology. The society is based in San Francisco, CA, and was founded in 1864 by Edward Delafield, Daniel Bennett St. John Roosa, and Henry Noyes. The private company addresses essential issues in medicine and advance the art and science of ophthalmology. The society holds annual meetings every third week of May each year, and they offer travel grants to non-members who wish to attend. Membership nominations are accepted until April 30th each year. | Corporate Officer/Principal | - | - |
Orphion Therapeutics, Inc.
Orphion Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Orphion Therapeutics, Inc. develops novel gene therapies for the treatment of genetic disorders. The private company is based in Great Neck, NY. The company was founded by Samuel I. Backenroth. The CEO is Jason Scott Slakter. | Direktor/Vorstandsmitglied | - | - |
Vorstandsvorsitzender | - | - |
Karriereverlauf von Jason Scott Slakter
Ehemalige bekannte Positionen von Jason Scott Slakter
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
Ohr Pharmaceutical, Inc.
Ohr Pharmaceutical, Inc. Pharmaceuticals: MajorHealth Technology Ohr Pharmaceutical, Inc. engages in the development of novel therapeutics and delivery technologies for the treatment of ocular disease. Its product portfolio includes squalamine and SKS sustained release technology. The company was founded by Irach B. Taraporewala in 2008 and is headquartered in New York, NY. | Direktor/Vorstandsmitglied | 01.01.2015 | 12.07.2019 |
Vorstandsvorsitzender | 01.09.2015 | 12.07.2019 | |
Technik-/Wissenschafts-/F&E-Leiter | 01.05.2014 | 07.08.2015 | |
Präsident | 01.09.2015 | 12.07.2019 | |
░░░ ░░░░░░ ░░░ | ░░░░░ ░░░░░░░░░ ░░░░░░░ | - | - |
░░░░░░░ | - | - | |
░░░░░░░░ ░░░░░░░░░░░░░░░░ ░░░░ | ░░░░░ ░░░░░░░░░░░░ ░░░░░░░ | - | - |
Statistik
International
Vereinigte Staaten | 12 |
Operativ
Corporate Officer/Principal | 6 |
Chief Executive Officer | 4 |
Chief Tech/Sci/R&D Officer | 3 |
Sektoral
Health Technology | 5 |
Commercial Services | 2 |
Consumer Services | 2 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
Private Unternehmen | 10 |
---|---|
Potentia Pharmaceuticals, Inc.
Potentia Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Potentia Pharmaceuticals, Inc. operates as a biotechnology company. It focuses on the development of novel therapeutics and drug delivery technologies to address chronic inflammatory diseases. The company was founded by Cedric Francois, David Darst, Alec Machiels and Pascal Deschatelets in 2001 and is headquartered in Crestwood, KY. | Health Technology |
Macula Society | |
American Ophthalmological Society
American Ophthalmological Society Miscellaneous Commercial ServicesCommercial Services The American Ophthalmological Society is an organization that aims to promote excellence in patient care, education, and research in the field of ophthalmology. The society is based in San Francisco, CA, and was founded in 1864 by Edward Delafield, Daniel Bennett St. John Roosa, and Henry Noyes. The private company addresses essential issues in medicine and advance the art and science of ophthalmology. The society holds annual meetings every third week of May each year, and they offer travel grants to non-members who wish to attend. Membership nominations are accepted until April 30th each year. | Commercial Services |
The Retina Society | |
American Society of Retinal Specialists | |
Ohr Pharmaceutical, Inc.
Ohr Pharmaceutical, Inc. Pharmaceuticals: MajorHealth Technology Ohr Pharmaceutical, Inc. engages in the development of novel therapeutics and delivery technologies for the treatment of ocular disease. Its product portfolio includes squalamine and SKS sustained release technology. The company was founded by Irach B. Taraporewala in 2008 and is headquartered in New York, NY. | Health Technology |
Orphion Therapeutics, Inc.
Orphion Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Orphion Therapeutics, Inc. develops novel gene therapies for the treatment of genetic disorders. The private company is based in Great Neck, NY. The company was founded by Samuel I. Backenroth. The CEO is Jason Scott Slakter. | Health Technology |
SKS Ocular LLC
SKS Ocular LLC BiotechnologyHealth Technology SKS Ocular, LLC is a private ophthalmology company incubator that uses state-of-the-art research and development technologies to discover and advance novel therapeutics through preclinical or clinical proof of concept. | Health Technology |
Jason S. Slakter MD PC
Jason S. Slakter MD PC Medical/Nursing ServicesHealth Services Part of ProScan Imaging LLC, Jason S. Slakter MD PC is an ophthalmology imaging core lab. The company is based in Great Neck, NY. The company was founded in 1998 by Jason Scott Slakter and Jeffrey Schneebaum. Jason Scott Slakter has been the CEO since 1998. Jason S. Slakter MD was acquired by WorldCare Clinical LLC on September 03, 2021. | Health Services |
Vitreous Retina Macula Consultants of New York |
- Börse
- Insiders
- Jason Scott Slakter
- Erfahrung